Lanean...
Neoadjuvant therapy for gastrointestinal stromal tumor
Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...
Gorde:
| Argitaratua izan da: | Transl Gastroenterol Hepatol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
AME Publishing Company
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/ https://ncbi.nlm.nih.gov/pubmed/29441368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|